Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore)

Hepatic dysfunction (HD) is common in patients with haematological malignancies. Hepatic haemophagocytosis (HH) was detected in >50% of liver biopsies taken when HD remained unresolved after standard examination. We aimed to explore the contribution of liver biopsy in patients with both haematolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bris, Pierre‐Nicolas, Gauchez, Philippe, Devillier, Raynier, Galicier, Lionel, Collignon, Aude, Piana, Gilles, Poizat, Flora, Faucher, Marion, Hospital, Marie‐Anne, Vey, Norbert, Gonzalez, Frederic, Servan, Luca, Chow‐Chine, Laurent, Sannini, Antoine, Mokart, Djamel, Saillard, Colombe, Bisbal, Magali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematological Malignancy‐biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805208/
https://www.ncbi.nlm.nih.gov/pubmed/35968907
http://dx.doi.org/10.1111/bjh.18382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805208/
https://www.ncbi.nlm.nih.gov/pubmed/35968907
http://dx.doi.org/10.1111/bjh.18382

Ejemplares similares